Publikationen 2014
Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advenced Rectal Cancer – A Phase II Clinical Trial
Eisterer W, De Vries A, Öfner D, Rabl H, Koplmüller R, Greil R, Tschmelitsch J, Schmid R, Kapp K, Lukas P, Sedlmayer F, Höfler G, Gnant M, Thaler J on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Anticancer Research – International Journal of Cancer Research and Treatment
34, 2014
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, van Laethem J, Thaler J, Bridgewater J, Norgard Peterson L, Blons H, Collette L, van Cutsen E, Rougier P, Salazar R, Bedenne L, Emile J, Laurent-Puig P, Lepage C
The Lancet Oncology
Early Online Publication June 11, 2014
The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
Filipits M, Nielsen T, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer C, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens J, Gnant M, for the Austrian Breast and Colorectal Cancer Study Group
Clinical Cancer Research
Published OnlineFirst February 11, 2014